Equities

Jack Nathan Medical Corp

  • Add to watchlist
  • Add to portfolio
  • Add an alert
JNH:CVE

Jack Nathan Medical Corp

Actions
  • Price (CAD)0.01
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change-60.00%
  • Beta-0.3192
Data delayed at least 15 minutes, as of Jun 10 2025.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Jack Nathan Medical Corp. is a provider of primary care medical clinics located in Walmart Supercentres under the Jack Nathan Health brand. Jack Nathan Health is a healthcare company focused on improving access for millions of patients by co-locating physician and ancillary medical services conveniently inside Walmart stores, providing patient care, made possible through patient-centric physicians, a variety of medical services, technology, and programs, designed to put patients first. Jack Nathan Health delivers turn-key medical centers. The Company operates approximately 175 locations globally, all corporately owned and operated. In Canada, the Company has about four corporate owned clinics in Alberta and Ontario, providing MedSpa services. In Mexico, the Company has about 171 corporate owned clinics across Mexico within three divisions, including 165 retail clinics, five clinics inside Walmart Distribution Centers servicing Walmart Associates, and one multidisciplinary clinic.

  • Revenue in CAD (TTM)7.47m
  • Net income in CAD604.88k
  • Incorporated2017
  • Employees24.00
  • Location
    Jack Nathan Medical Corp6-6150 Highway 6,, Suite 491WOODBRIDGE L4H 0R6CanadaCAN
  • Phone+1 (416) 637-2240
  • Fax+1 (416) 663-5000
  • Websitehttps://www.jacknathanhealth.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Element Lifestyle Retirement Inc1.12m64.19k704.78k--10.99--9.650.62860.00090.00090.0159-0.00990.8803--10.76--5.04-31.866.74-36.52----5.72-50.68--0.55821.68--2.6554.8955.95---38.07--
Newtopia Inc6.71m-7.26m866.33k100.00------0.1291-0.044-0.0440.0402-0.07272.2032.186.37---238.08-144.42----49.8848.74-108.09-81.390.043-1.52-----12.3826.0614.29---42.99--
Jack Nathan Medical Corp7.47m604.88k870.99k24.001.449.710.77090.11670.0070.12410.08570.0011.73--7.38--14.03-73.5055.95-132.35----8.10-64.38---7.380.6968--26.4119.20-89.79--35.78--
ARCpoint Inc5.54m2.99m1.28m--0.3088--0.34070.23170.03240.03240.0499-0.1310.9099--6.94--49.85------69.27--54.79-----12.715.96---17.43--115.67------
Universal Ibogaine Inc2.06m-1.48m1.56m----5.67--0.7593-0.0052-0.00520.00690.00090.4419--4.99---31.67---47.71--17.31---71.66-----4.880.9043--126.32--14.17------
AJA Health And Wellness Inc131.10k-3.26m3.03m----1.23--23.14-0.175-0.1750.00520.02850.0774-------192.06-62.76---343.4961.94---2,483.09-578,671.90---1.890.0562-------146.86------
Data as of Jun 10 2025. Currency figures normalised to Jack Nathan Medical Corp's reporting currency: Canadian Dollar CAD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.